Blue Yonder Recognized as a Leader in Nucleus Research Supply Chain Planning Value Matrix 2022
Leadership ranking is attributed to Blue Yonder’s ability to deliver value to customers through the…
Month: April 2022
Five Universal Fundamentals for Securing Your Cloud
Organizations That Have Implemented Effective Cloud Security Programs Share Characteristics That Any Enterprise Can Emulate…
Highland Electric, One-Stop-Shop for Affordable Adoption of Electrified School Buses, Delivers Seamless Fleet Management With Synop
Sophisticated management solution built from the ground up specifically to optimize electrified fleets enables customers…
E2open Upsizes Existing Credit Agreement by $190 Million
AUSTIN, Texas–(BUSINESS WIRE)–E2open Parent Holdings, Inc. (NYSE: ETWO), a leading network-based provider of a cloud-based,…
Vontive Launches with $135 Million in New Funding to Transform Real Estate Investing
Company delivers the first platform that allows any business to embed a mortgage at the…
Zenoss Chief Revenue Officer Pritesh Upadhyay Named a Top 25 Sales Executive of 2022
Sales and Technology Veteran Recognized for His Success Ensuring Top-Line Growth and Market Expansion AUSTIN,…
Castellum, Inc. Announces Accretive Restructuring and $1.5 Million Investment for Uplisting from Crom Cortana Fund LLC
Castellum, Inc. Announces Accretive Restructuring and $1.5 Million Investment for Uplisting from Crom Cortana Fund…
Fortress Biotech to Present at the 21st Annual Needham Virtual Healthcare Conference
MIAMI, April 07, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative…
CorMedix Inc. Announces Scientific Advisory Board to Support Commercialization and Pipeline Development
BERKELEY HEIGHTS, N.J., April 07, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a…
Bolt Biotherapeutics to Present at 21st Annual Needham Healthcare Conference
REDWOOD CITY, Calif., April 07, 2022 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage…
Impel NeuroPharma To Present At The 21st Annual Needham Healthcare Conference
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) — Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company…
Rubius Therapeutics to Host Investor Webcast to Discuss Updated Clinical Data at AACR from the Ongoing Monotherapy Phase 1 Arm of the Phase 1/2 Clinical Trial of RTX-240 in Patients with Advanced Solid Tumors on April 8, 2022, at 1:15 PM ET
CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage…
Neoleukin Therapeutics to Present at Canaccord Genuity Horizons in Oncology Conference
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Propella Therapeutics Announces Licensing Agreement with Jiangsu Aosaikang Pharmaceutical Co. Ltd. (ASK Pharm) for Development and Commercial Rights to CGS-200-5 in Greater China
Propella to Receive Upfront Payment, Regulatory and Sales Milestones, and Royalties Phase 2 Study of…
VYNE Therapeutics Announces Positive Phase 1b Efficacy Data for FMX114 from Phase 1b/2a Trial for the Treatment of Mild-to-Moderate Atopic Dermatitis
At week 2, FMX114 demonstrated a statistically significant reduction in both absolute and percent change…
Lexicon Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference
THE WOODLANDS, Texas, April 07, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today…
LianBio Appoints Wei Wei Chen to Board of Directors
SHANGHAI and PRINCETON, N.J., April 07, 2022 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology…
Apexigen Announces That New Data From Phase 2 Trial Evaluating its CD40 Antibody Sotigalimab in Combination With Pembrolizumab in Patients With Metastatic Melanoma Will Be Presented at the AACR Annual Meeting 2022
Data to be featured in an oral presentation on April 12, 2022 at 3:35pm (CDT)…
Harpoon Therapeutics to Participate in Canaccord Genuity Horizons in Oncology Virtual Conference
SOUTH SAN FRANCISCO, Calif., April 07, 2022 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP),…